Press releases

An inhibitor of a fat-degrading protein can protect against heart failure. Researchers at the German Centre for Cardiovascular Research (DZHK) at the…

The global cardiovascular research community is joining forces: eleven leading and independent funding organisations from Australia, Canada, Denmark,…

Temporarily discontinuing ACE inhibitors and angiotensin receptor blockers does not affect the severity of COVID-19 disease, but it could have a…

Exercise in polluted air above a certain threshold may cause cardiovascular side effects because high levels of particulate matter. This proves a…

Atrial fibrillation, a common heart rhythm disorder, does not come back as quickly in obese people if they lose weight after catheter ablation, which…

Recovering from a corona infection at home - that's what most people want to do. But sometimes hospitalization is unavoidable. But when is the right…

A small, wearable heart monitor can detect atrial fibrillation in high-risk patients ten times more frequently than standard tests. This is the result…

Cardiac arrhythmias were the most common cardiovascular problem in hospitalized COVID-19 patients. This is shown in an evaluation by scientists of the…

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used to treat patients with heart failure.…

Diastolic heart failure can be reliably detected with a newly developed magnetic resonance imaging (MRI) technology, shows a study by the German…